Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01607710 · ClinicalTrials.gov registry record
Locating Regions of Interest in Generalized Anxiety Disorder Using Function Magnetic Resonance Imaging (fMRI)
A clinical trial, sponsored by Hartford Hospital.
- Completed
- Registry status
- 55
- Enrollment target
NCT01607710 is a clinical trial that has completed, run by Hartford Hospital. The registered enrollment target is 55 participants.
The verdict
NCT01607710 has completed, sponsored by Hartford Hospital.
- COMPLETED
- Registry status
- 55 participants
- Enrollment target
Study Summary
The investigators are seeking to locate the brain regions of interest in generalized anxiety disorder (GAD) using both structural (sMRI) and functional magnetic resonance imaging (fMRI). The MRI will be used to measure changes in blood flow in the brain while at rest and while completing tasks designed to elicit symptoms of anxiety. Results from a nonclinical control group and a GAD group will be compared to determine whether they exhibit different areas of brain activity during the tasks.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2012-07 |
| Est. Completion | 2014-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01607710
The ClinicalTrials.gov registry entry for NCT01607710 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hartford Hospital, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01607710 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01607710 about?
NCT01607710 is a clinical study titled "Locating Regions of Interest in Generalized Anxiety Disorder Using Function Magnetic Resonance Imaging (fMRI)". The investigators are seeking to locate the brain regions of interest in generalized anxiety disorder (GAD) using both structural (sMRI) and functional magnetic resonance imaging (fMRI). The MRI will be used to measure changes in blood flow in the brain while at rest and while completing tasks desig...
What is the current status of trial NCT01607710?
This trial is currently completed. The enrollment target is 55 participants. The study started on 2012-07. Estimated completion is 2014-06.
Who is sponsoring clinical trial NCT01607710?
This trial is sponsored by Hartford Hospital, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.